Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...
"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...
Rutgers Health researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants ...
News Medical on MSN1d
Study explores whether dietary supplement could provide first effective treatment for cirrhosisThe BOOST trial - led by researchers at the University of Plymouth and experts across the UK - will assess whether the Β-hydroxy β-methylbutyrate (HMB) supplement can benefit some of the 60,000 people ...
Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...
Akero's SYMMETRY Phase 2b study showed 50mg EFX achieved 24% cirrhosis reversal in MASH patients, with improvements in liver ...
Medical Xpress on MSN11d
Unique characteristics of a rare liver cancer identified as clinical trial of new treatment beginsMoreover, drug therapies for common liver cancers are not just useless for FLC patients but actually harmful. But new ...
Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...
A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...
Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results